Bradley Burnam

Latest round: Series B. Bradley Burnam is the CEO of Turn Therapeutics, a biotech company.

About Bradley Burnam

Bradley Burnam is the CEO of Turn Therapeutics, a biotech company. He founded the company after developing a cure for himself. Turn Therapeutics has secured an investment commitment tied to a public listing and has obtained three FDA clearances, 16 patents, and achieved over 200,000 patient uses.

Bradley Burnam at a glance

More founder profiles (44)

Browse related founder lists (1)

Full founder directory · Investor directory · Company funding database · Fundraising library